Details of the Drug

General Information of Drug (ID: DMMNLWI)

• Drug Name: AGS-003

Indication

Disease Entry	ICD 11	Status	REF
Migraine	8A80	Phase 2	[1]
Renal cell carcinoma	2C90	Phase 2	[1]

• Cross-matching ID: TTD ID: D0Q5OC
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01482949) A Rollover Protocol for Subjects Previously Treated With AGS-003. U.S. National Institutes of Health.